Tender detail

Open-house discount agreements for biologics 2026-09 – etanercept

Summary

The participating health insurance funds seek to conclude rebate agreements with pharmaceutical companies for the active substance etanercept under the open-house procedure. The agreements use uniform terms, involve no individual negotiations and do not grant exclusivity. The contract period begins on 1 May 2026 and ends no later than 30 April 2028, with a maximum duration of 24 months; participation is possible at any time during the contract period.

Reference number
abaf4b6b-22a4-48be-b9fb-20e1c7802863
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2026-12-31
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.